Most brain cancer diagnoses in the United States are glioma, and MERIT’s webinar explored the challenges and potential solutions for assessing these tumors. New therapies are being studied through clinical trials, many of which use response criteria such as Response Assessment in Neuro-Oncology (RANO). This...
Resources
Our articles provide quick read summaries to help keep you informed and looking forward with industry insights.
Idiopathic Pulmonary Fibrosis (IPF) is the most common type of PF, and its prevalence is on the rise globally. Numerous Phase 2 and Phase 2b/3 trials are underway for the development of new IPF treatments. ...
Article, Clinical Endpoint Experts / 09.08.2023
4 Reasons to Partner with a Respiratory Clinical Endpoint Expert
Discover 4 reasons to partner with a clinical endpoint expert for your next respiratory trial....
Learn five facts about the current state of clinical trials including details about trial costs, enrollment issues, and the difficulty and complexity of today's studies....
Article, Oncology / 21.06.2023
Treating Lung Cancer with Antibody-Drug Conjugates: Advancing Clinical Trials
Given that the relative survival rate of patients diagnosed with metastatic lung cancer is low, and that traditional chemotherapy and surgery are of limited efficacy, ADCs represent a potentially important treatment option....
Article / 01.06.2023
Validating Your Imaging Data to Secure Funding: Collect and Hold MERIT Webinar Takeaways
MERIT’s most recent webinar provided an interactive Q & A style session discussing how early phase centralized image storage can help sponsors secure funding. ...
Webinars
Tune into our webinars for subject matter expertise on a variety of key topics.
Effective Reader Monitoring Plans & Variability QC for ADC, Immuno-oncology, Cancer Cell Therapy & Radiopharmaceutical Studies
May 22, 2024 | 11 AM EST
Duration: 45 Minutes
OCT Evaluation of Neovascular AMD in Clinical Trials:
A Reading Center Perspective
A Reading Center Perspective
Feb 22, 2024 | 11 AM EST
Duration: 45 Minutes
Navigating Neuro-Oncology: Understanding Pseudoprogression and Harnessing PsP Outcomes for Optimal Imaging Assessment
Nov 15, 2023 | 5:30 PM ET
Duration: 45 Minutes
Events
We enjoy meeting sponsors, partners, and industry professionals! Network with us at an upcoming conference.
ESMO Congress
European Society for Medical Oncology
Sep 13-17, 2024 | Barcelona, Spain
Booth #612
OCT Southern CA
Outsourcing in Clinical Trials
Sep 24-25, 2024 | La Jolla, CA
Booth #1
AAO Annual Meeting
American Academy of Ophthalmology
Oct 18-21, 2024 | Chicago, IL
Booth #3433
Case Studies
Looking for real-world examples of how MERIT has supported sponsor clinical trial endpoints?
Uncategorized / 08.04.2024
Time Savings Gained in Retrospective Study of Glioma
MERIT provided fast, accurate reads to support the quick turnaround times of a biotech's retrospective review of an early phase Glioma study. ...
Uncategorized / 08.04.2024
Cost Savings in Newly Diagnosed Glioblastoma Multiforme (GBM) Trial
MERIT was engaged mid-study to supply the high-quality imaging data and expertise needed to keep a Phase II glioblastoma study on track. Learn how this resulted in a significant cost savings for the Sponsor....
Uncategorized / 26.06.2023
Complex Global Imaging Study in Pediatric Population
Anti-VEGF treatment via intravitreal injection has the potential to offer improved outcomes in the high-risk, vulnerable premature newborn population with ROP. Learn more in our case study. ...
Learn how high-quality retinal images were key to this pilot study’s success and formed the basis for testing an AI algorithm....
Solution Guides
Our Solutions Guides provide an in-depth look at MERIT’s services, capabilities, and expertise.
MERIT BCVA Certification Guide
MERIT Ophthalmology Imaging Solutions Guide
MERIT Oncology Imaging Solutions Guide
Info Sheets
Our Info Sheets are all downloadable and include helpful checklists, challenge and solution guides, and additional brief cheat sheets.
White Papers
Looking for in-depth information on industry trends and how MERIT is helping sponsors and CROs address the challenges and opportunities of today’s market?
Learn about disease states, viral and non-viral vectors, routes of delivery, specialized endpoints, and future directions for gene therapy in the treatment of IRDs....
/ 21.03.2022
Advances in Ultra-Wide Field Imaging
Learn how UWF imaging contributes to understanding pathology in the peripheral retina (particularly with diabetic retinopathy), about current UWF imaging systems, and potential future innovations....
In this white paper you will learn four potential issues presented in MBPCs and how you can solve for these with MERIT....
News
Featured news/media releases.
/ 07.06.2023
MERIT Achieves ISO 27001 Certification
/ 15.11.2022
FDA Expands 510(k) Clearance for MERIT’s Cloud-Based Imaging Management Platform, EXCELSIOR
MERIT's EXCELSIOR imaging software has received expansion of its FDA 510(k) market clearance (K#220929). The expanded clearance includes new indications for use such as interpretation and evaluation of radiologic images (CT, MR and PET) in clinical trials....